Abivax stock plummeted Tuesday after several patients developed cancer following a study of its ulcerative colitis treatment.

A clinical trial update wiped out billions in the French company's market cap and raised questions over a potential takeover.

Abivax (NASDAQ:ABVX) shares fell sharply on Tuesday after investors focused on reports of rare malignancy cases in a ...

Abivax said its experimental treatment for ulcerative colitis showed significant efficacy in a closely watched trial, but ...

Abivax (ABVX) plunged in premarket trading on Tuesday despite announcing positive Phase 3 maintenance trial results for its ...

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative ColitisAt ...

Can Surgery Cure Ulcerative Colitis? Alan Moss, MD, chief scientific officer of the Crohns & Colitis Foundation, clearly explains the surgeries available to people with ulcerative colitis, and their ...

Add Yahoo as a preferred source to see more of our stories on Google. “Debilitating digestive issues dominated my life because I couldn’t go longer than a half hour without going to the bathroom,” ...

GRAND RAPIDS, Mich. — You can help get closer to cures for inflammatory bowel disease (IBD) and support loved ones living with these conditions by taking a simple walk! June 22, The Crohn’s & Colitis ...